Michelle Archer

468 total citations
8 papers, 308 citations indexed

About

Michelle Archer is a scholar working on Molecular Biology, Infectious Diseases and Pharmaceutical Science. According to data from OpenAlex, Michelle Archer has authored 8 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Pharmaceutical Science. Recurrent topics in Michelle Archer's work include Drug Solubulity and Delivery Systems (3 papers), Protein purification and stability (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Michelle Archer is often cited by papers focused on Drug Solubulity and Delivery Systems (3 papers), Protein purification and stability (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Michelle Archer collaborates with scholars based in United States and Canada. Michelle Archer's co-authors include Ryan M. Kramer, Christopher B. Fox, Elise Larson, Neal Van Hoeven, Alana Gerhardt, Brian Granger, Emily Gage, Natasha Dubois Cauwelaert, Steven G. Reed and Amit P. Khandhar and has published in prestigious journals such as The Journal of Immunology, International Journal of Pharmaceutics and Molecular Therapy.

In The Last Decade

Michelle Archer

8 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Archer United States 6 161 118 94 52 51 8 308
Veerupaxagouda Patil United States 13 116 0.7× 97 0.8× 128 1.4× 29 0.6× 17 0.3× 23 342
Ruchi R. Shah United States 4 108 0.7× 60 0.5× 144 1.5× 28 0.5× 14 0.3× 5 256
David E. Anderson United States 10 103 0.6× 105 0.9× 86 0.9× 72 1.4× 9 0.2× 21 328
Hoang Hirschberg Netherlands 11 68 0.4× 88 0.7× 131 1.4× 166 3.2× 24 0.5× 14 379
Koen Allosery Belgium 3 141 0.9× 161 1.4× 94 1.0× 16 0.3× 79 1.5× 4 423
Priyal Bagwe United States 9 74 0.5× 73 0.6× 116 1.2× 147 2.8× 16 0.3× 22 291
Stacy Strom Canada 10 48 0.3× 56 0.5× 129 1.4× 15 0.3× 16 0.3× 13 284
Elyse A. Beebe United States 11 127 0.8× 206 1.7× 250 2.7× 19 0.4× 17 0.3× 12 404
Christopher L. D. McMillan Australia 11 134 0.8× 204 1.7× 83 0.9× 38 0.7× 18 0.4× 20 380
H J Steger United States 7 47 0.3× 126 1.1× 137 1.5× 38 0.7× 31 0.6× 11 395

Countries citing papers authored by Michelle Archer

Since Specialization
Citations

This map shows the geographic impact of Michelle Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Archer more than expected).

Fields of papers citing papers by Michelle Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Archer. The network helps show where Michelle Archer may publish in the future.

Co-authorship network of co-authors of Michelle Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Archer. A scholar is included among the top collaborators of Michelle Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Archer. Michelle Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Archer, Michelle, Hong Liang, Dawn M. Fedor, et al.. (2023). Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine. Heliyon. 9(6). e17325–e17325. 1 indexed citations
2.
Gerhardt, Alana, Emily A. Voigt, Michelle Archer, et al.. (2022). A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery. Molecular Therapy — Methods & Clinical Development. 25. 205–214. 56 indexed citations
3.
Archer, Michelle, David Barona, Hui Wang, et al.. (2021). Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying. European Journal of Pharmaceutics and Biopharmaceutics. 163. 23–37. 21 indexed citations
4.
Wang, Hui, Mani Ordoubadi, Nicholas B. Carrigy, et al.. (2020). Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate. International Journal of Pharmaceutics. 593. 120121–120121. 40 indexed citations
5.
Kramer, Ryan M., Michelle Archer, Mark T. Orr, et al.. (2018). Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach. International Journal of Nanomedicine. Volume 13. 3689–3711. 30 indexed citations
6.
Erasmus, Jesse H., Amit P. Khandhar, Jeff Guderian, et al.. (2018). A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika. Molecular Therapy. 26(10). 2507–2522. 118 indexed citations
7.
Seydoux, Emilie, Hong Liang, Natasha Dubois Cauwelaert, et al.. (2018). Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses. The Journal of Immunology. 201(1). 98–112. 38 indexed citations
8.
Fedor, Dawn M., Simon H. Williams, Quinton M. Dowling, et al.. (2016). Lyophilization of an Adjuvanted Mycobacterium tuberculosis Vaccine in a Single-Chamber Pharmaceutical Cartridge. AAPS PharmSciTech. 18(6). 2077–2084. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026